| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | enzyme regulator activity | ARL2BP CLSTN3 DENND4A ERCC4 RASA1 PPP2R2D MYO9B ANXA1 OBSCN GCGR ARHGAP39 GRM5 DENND1A USP14 SH3PXD2B KAT2B PLEKHG3 BTK RIMS1 TNS3 | 3.76e-05 | 1418 | 104 | 20 | GO:0030234 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARL2BP DENND4A RASA1 MYO9B OBSCN GCGR ARHGAP39 DENND1A PLEKHG3 RIMS1 TNS3 | 6.74e-05 | 507 | 104 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARL2BP DENND4A RASA1 MYO9B OBSCN GCGR ARHGAP39 DENND1A PLEKHG3 RIMS1 TNS3 | 6.74e-05 | 507 | 104 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | cholesterol-protein transferase activity | 8.03e-05 | 3 | 104 | 2 | GO:0140853 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | DENND4A MYO9B OBSCN ARHGAP39 DENND1A PLEKHG3 AGRN NOTCH2 TNS3 | 4.79e-05 | 333 | 104 | 9 | GO:0051056 |
| GeneOntologyBiologicalProcess | actin filament-based process | FLNB KRT8 NRAP RASA1 DSP MYO9B ANXA1 SPTBN2 OBSCN SORBS1 SH3PXD2B CACNA1H KIT PHLDB2 FCHSD1 | 5.19e-05 | 912 | 104 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 5.35e-05 | 41 | 104 | 4 | GO:0051084 | |
| GeneOntologyBiologicalProcess | intein-mediated protein splicing | 7.53e-05 | 3 | 104 | 2 | GO:0016539 | |
| GeneOntologyBiologicalProcess | protein splicing | 7.53e-05 | 3 | 104 | 2 | GO:0030908 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 8.46e-05 | 46 | 104 | 4 | GO:0006458 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT7 KRT8 B4GALT7 EPPK1 NRAP RASA1 DSP SPTBN2 OBSCN SORBS1 KATNAL1 TUBGCP5 SH3PXD2B PHLDB2 FCHSD1 | 8.91e-05 | 957 | 104 | 15 | GO:0097435 |
| GeneOntologyBiologicalProcess | cell morphogenesis | FLNB VPREB1 CLSTN3 RASA1 MNX1 MYO9B ANXA1 DRGX CC2D1A PLXNA4 RIMS1 FLRT3 TBR1 IHH KIT AGRN NOTCH2 | 9.45e-05 | 1194 | 104 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | epithelial cell-cell adhesion | 9.62e-05 | 18 | 104 | 3 | GO:0090136 | |
| GeneOntologyBiologicalProcess | muscle structure development | FLNB KRT8 DDX17 NRAP MNX1 DSP OBSCN PLD3 DUSP29 KMT5B ZFHX3 CACNA1H KIT NOTCH2 | 1.03e-04 | 858 | 104 | 14 | GO:0061061 |
| GeneOntologyBiologicalProcess | intrahepatic bile duct development | 1.50e-04 | 4 | 104 | 2 | GO:0035622 | |
| GeneOntologyCellularComponent | I band | 1.94e-06 | 166 | 105 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | anchoring junction | FLNB KRT8 GAK EPPK1 NRAP SYNM DSP ANXA1 SPTBN2 OBSCN SNAP23 SORBS1 SH3PXD2B FLRT3 KIT PHLDB2 TNS3 | 7.04e-06 | 976 | 105 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | Z disc | 1.12e-05 | 151 | 105 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 3.73e-05 | 249 | 105 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | cell-cell junction | KRT8 EPPK1 NRAP SYNM DSP ANXA1 SPTBN2 OBSCN SNAP23 SORBS1 FLRT3 KIT | 4.16e-05 | 591 | 105 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | glutamatergic synapse | DNAJB1 AMPH CLSTN3 SPTBN2 SNAP23 CC2D1A ARHGAP39 GRM5 USP14 PLXNA4 CACNA1H RIMS1 FLRT3 AGRN | 5.88e-05 | 817 | 105 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | myofibril | 7.13e-05 | 273 | 105 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | cell-substrate junction | 7.92e-05 | 443 | 105 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.09e-04 | 290 | 105 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcolemma | 3.98e-04 | 190 | 105 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | centrosome | ARL2BP TTC28 CEP290 CC2D1A SORBS1 KATNAL1 TUBGCP5 RBM39 KAT2B BRCA1 ERCC6L2 CTNNBL1 | 4.85e-04 | 770 | 105 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNB AMPH MYO9B ANXA1 SPTBN2 SORBS1 SH3PXD2B KAT2B TNS3 FCHSD1 | 6.45e-04 | 576 | 105 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | supramolecular fiber | FLNB KRT7 KRT8 IGFN1 EPPK1 NRAP SYNM DSP MYO9B ANXA1 OBSCN DNAJB4 KATNAL1 TUBGCP5 KAT2B | 7.97e-04 | 1179 | 105 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | FLNB KRT7 KRT8 IGFN1 EPPK1 NRAP SYNM DSP MYO9B ANXA1 OBSCN DNAJB4 KATNAL1 TUBGCP5 KAT2B | 8.54e-04 | 1187 | 105 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | gamma-tubulin ring complex | 1.33e-03 | 11 | 105 | 2 | GO:0000931 | |
| GeneOntologyCellularComponent | focal adhesion | 1.49e-03 | 431 | 105 | 8 | GO:0005925 | |
| GeneOntologyCellularComponent | fascia adherens | 1.88e-03 | 13 | 105 | 2 | GO:0005916 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 2.13e-03 | 263 | 105 | 6 | GO:0045111 | |
| GeneOntologyCellularComponent | microtubule organizing center | ARL2BP TTC28 CEP290 CC2D1A SORBS1 KATNAL1 TUBGCP5 RBM39 KAT2B BRCA1 ERCC6L2 CTNNBL1 | 2.21e-03 | 919 | 105 | 12 | GO:0005815 |
| Domain | Hedgehog_signalling_dom | 8.83e-05 | 3 | 102 | 2 | IPR000320 | |
| Domain | HintN | 8.83e-05 | 3 | 102 | 2 | SM00306 | |
| Domain | HintC | 8.83e-05 | 3 | 102 | 2 | SM00305 | |
| Domain | Hedgehog | 8.83e-05 | 3 | 102 | 2 | IPR001657 | |
| Domain | HH_signal | 8.83e-05 | 3 | 102 | 2 | PF01085 | |
| Domain | Hint | 8.83e-05 | 3 | 102 | 2 | PF01079 | |
| Domain | Hedgehog_sig/DD-Pept_Zn-bd_dom | 8.83e-05 | 3 | 102 | 2 | IPR009045 | |
| Domain | Hint_dom | 8.83e-05 | 3 | 102 | 2 | IPR001767 | |
| Domain | - | 8.83e-05 | 3 | 102 | 2 | 3.30.1380.10 | |
| Domain | Hint_dom_N | 8.83e-05 | 3 | 102 | 2 | IPR003587 | |
| Domain | Hint_dom_C | 8.83e-05 | 3 | 102 | 2 | IPR003586 | |
| Domain | DnaJ | 1.36e-04 | 48 | 102 | 4 | PF00226 | |
| Domain | DNAJ_1 | 1.47e-04 | 49 | 102 | 4 | PS00636 | |
| Domain | DNAJ_2 | 1.47e-04 | 49 | 102 | 4 | PS50076 | |
| Domain | DnaJ | 1.47e-04 | 49 | 102 | 4 | SM00271 | |
| Domain | - | 1.47e-04 | 49 | 102 | 4 | 1.10.287.110 | |
| Domain | DnaJ_domain | 1.72e-04 | 51 | 102 | 4 | IPR001623 | |
| Domain | Hedgehog/Intein_dom | 1.76e-04 | 4 | 102 | 2 | IPR028992 | |
| Domain | - | 1.76e-04 | 4 | 102 | 2 | 2.170.16.10 | |
| Domain | SH3 | 1.83e-04 | 216 | 102 | 7 | SM00326 | |
| Domain | SH3 | 1.83e-04 | 216 | 102 | 7 | PS50002 | |
| Domain | SH3_domain | 2.05e-04 | 220 | 102 | 7 | IPR001452 | |
| Domain | SH3_1 | 2.81e-04 | 164 | 102 | 6 | PF00018 | |
| Domain | - | 4.37e-04 | 6 | 102 | 2 | 3.90.1290.10 | |
| Domain | Plectin | 6.09e-04 | 7 | 102 | 2 | PF00681 | |
| Domain | Plectin_repeat | 6.09e-04 | 7 | 102 | 2 | IPR001101 | |
| Domain | PLEC | 6.09e-04 | 7 | 102 | 2 | SM00250 | |
| Domain | PTEN_C2 | 8.09e-04 | 8 | 102 | 2 | PF10409 | |
| Domain | PTEN_C2 | 8.09e-04 | 8 | 102 | 2 | SM01326 | |
| Domain | C2_TENSIN | 8.09e-04 | 8 | 102 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 8.09e-04 | 8 | 102 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 8.09e-04 | 8 | 102 | 2 | IPR014020 | |
| Domain | DnaJ_C | 1.04e-03 | 9 | 102 | 2 | IPR002939 | |
| Domain | DnaJ_C | 1.04e-03 | 9 | 102 | 2 | PF01556 | |
| Domain | HSP40/DnaJ_pept-bd | 1.04e-03 | 9 | 102 | 2 | IPR008971 | |
| Domain | PPASE_TENSIN | 1.04e-03 | 9 | 102 | 2 | PS51181 | |
| Domain | SH3_2 | 1.26e-03 | 86 | 102 | 4 | PF07653 | |
| Domain | SH3_2 | 1.26e-03 | 86 | 102 | 4 | IPR011511 | |
| Domain | Rho_GTPase_activation_prot | 1.38e-03 | 88 | 102 | 4 | IPR008936 | |
| Domain | PH | 1.61e-03 | 229 | 102 | 6 | PF00169 | |
| Domain | C2_dom | 2.06e-03 | 164 | 102 | 5 | IPR000008 | |
| Domain | SH2 | 2.28e-03 | 101 | 102 | 4 | PF00017 | |
| Domain | uDENN | 2.57e-03 | 14 | 102 | 2 | SM00800 | |
| Domain | uDENN | 2.96e-03 | 15 | 102 | 2 | PF03456 | |
| Domain | TPR_8 | 3.04e-03 | 53 | 102 | 3 | PF13181 | |
| Domain | SH2 | 3.11e-03 | 110 | 102 | 4 | SM00252 | |
| Domain | SH2 | 3.21e-03 | 111 | 102 | 4 | PS50001 | |
| Domain | SH2 | 3.32e-03 | 112 | 102 | 4 | IPR000980 | |
| Domain | - | 3.32e-03 | 112 | 102 | 4 | 3.30.505.10 | |
| Domain | DENN | 3.37e-03 | 16 | 102 | 2 | SM00799 | |
| Domain | DENN | 3.37e-03 | 16 | 102 | 2 | PF02141 | |
| Domain | dDENN | 3.37e-03 | 16 | 102 | 2 | PF03455 | |
| Domain | UDENN | 3.37e-03 | 16 | 102 | 2 | PS50946 | |
| Domain | DDENN | 3.37e-03 | 16 | 102 | 2 | PS50947 | |
| Domain | dDENN | 3.37e-03 | 16 | 102 | 2 | SM00801 | |
| Domain | dDENN_dom | 3.37e-03 | 16 | 102 | 2 | IPR005112 | |
| Domain | uDENN_dom | 3.37e-03 | 16 | 102 | 2 | IPR005113 | |
| Domain | DENN | 3.37e-03 | 16 | 102 | 2 | PS50211 | |
| Domain | DENN_dom | 3.37e-03 | 16 | 102 | 2 | IPR001194 | |
| Domain | PH | 4.21e-03 | 278 | 102 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.29e-03 | 279 | 102 | 6 | PS50003 | |
| Domain | PH_domain | 4.36e-03 | 280 | 102 | 6 | IPR001849 | |
| Domain | Pyr_redox_2 | 4.75e-03 | 19 | 102 | 2 | PF07992 | |
| Domain | Intermediate_filament_CS | 4.95e-03 | 63 | 102 | 3 | IPR018039 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB RBM15 EPPK1 DDX17 DSP MYO9B ANXA1 UGGT1 SPTBN2 CEP290 SNAP23 ABCF2 PLD3 CBR1 RBM39 XAB2 CHCHD3 GANAB AIFM1 PLEKHG3 PHLDB2 | 4.30e-12 | 1024 | 106 | 21 | 24711643 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | DNAJB1 FLNB KRT7 LPCAT1 EPPK1 PPP2R2D DSP ANXA1 UGGT1 PLD3 CBR1 GANAB AIFM1 FBXO21 TNS3 | 1.28e-09 | 647 | 106 | 15 | 26618866 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DNAJB1 FLNB AMPD2 KRT7 KRT8 LPCAT1 EPPK1 DDX17 DSP ANXA1 UGGT1 DNAJB4 ABCF2 CC2D1A CBR1 RBM39 XAB2 CHCHD3 GANAB AIFM1 CTNNBL1 | 1.59e-09 | 1415 | 106 | 21 | 28515276 |
| Pubmed | DNAJB1 RBM15 KRT8 DNAJC13 PPP2R2D DSP GOLM2 UGGT1 SPTBN2 CEP290 CTDSP1 ARHGAP39 GANAB DUSP29 AIFM1 UTP3 FKBP5 TNS3 | 2.93e-09 | 1049 | 106 | 18 | 27880917 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB RBM15 DNAJC13 DDX17 DSP MYO9B ANXA1 RSF1 ABCF2 CBR1 RBM39 USP14 NSUN5 CHCHD3 AIFM1 PLEKHG3 CTNNBL1 AGRN PHLDB2 TNS3 | 4.41e-09 | 1353 | 106 | 20 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DNAJB1 FLNB AMPD2 LPCAT1 DNAJC13 EPPK1 DDX17 DSP ANXA1 UGGT1 DNAJB4 CBR1 RBM39 XAB2 USP14 SH3PXD2B AIFM1 CTNNBL1 PHLDB2 TNS3 | 5.24e-09 | 1367 | 106 | 20 | 32687490 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DNAJB1 AMPD2 RBM15 KRT8 DENND4A TTC28 DSP CC2D1A SORBS1 TRIM68 DENND1A SH3PXD2B PLEKHG3 NOTCH2 PHLDB2 TNS3 | 8.02e-09 | 861 | 106 | 16 | 36931259 |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 19419944 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNB RBM15 KRT8 EPPK1 DDX17 SYNM DSP ANXA1 UGGT1 SPTBN2 ABCF2 RBM39 XAB2 NSUN5 CHCHD3 PLEKHG3 UTP3 PHLDB2 | 4.67e-08 | 1257 | 106 | 18 | 36526897 |
| Pubmed | A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. | 6.20e-08 | 34 | 106 | 5 | 12577067 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB DNAJC13 RASA1 GOLM2 OBSCN KATNAL1 ARHGAP39 PLD3 DENND1A RBM39 USP14 TNRC18 PLEKHG3 ZFHX3 CACNA1H RIMS1 FBXO21 FKBP5 NOTCH2 | 1.15e-07 | 1489 | 106 | 19 | 28611215 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | FLNB DDX17 DSP CEP290 OBSCN SNAP23 CBR1 GANAB PLEKHG3 TRIM38 FKBP5 | 2.06e-07 | 468 | 106 | 11 | 36042349 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.09e-07 | 202 | 106 | 8 | 33005030 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | FLNB KRT7 KRT8 EPPK1 DDX17 PPP2R2D DSP ANXA1 SPTBN2 SNAP23 RBM39 ALPL | 2.19e-07 | 580 | 106 | 12 | 35676659 |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 11013209 | ||
| Pubmed | 3.11e-07 | 488 | 106 | 11 | 31324722 | ||
| Pubmed | 4.50e-07 | 152 | 106 | 7 | 16009940 | ||
| Pubmed | Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganization. | 5.47e-07 | 6 | 106 | 3 | 25617501 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 9.78e-07 | 107 | 106 | 6 | 20508642 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNB RBM15 EPPK1 DDX17 DSP ANXA1 SPTBN2 ABCF2 RBM39 NSUN5 GANAB PLEKHG3 RBMX2 UTP3 | 1.19e-06 | 949 | 106 | 14 | 36574265 |
| Pubmed | 1.21e-06 | 346 | 106 | 9 | 25324306 | ||
| Pubmed | 1.68e-06 | 360 | 106 | 9 | 33111431 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.72e-06 | 361 | 106 | 9 | 26167880 | |
| Pubmed | Prox2 and Runx3 vagal sensory neurons regulate esophageal motility. | 1.83e-06 | 29 | 106 | 4 | 37192624 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DNAJB1 FLNB DNAJC13 DSP ANXA1 SNAP23 CC2D1A PLD3 CBR1 CHCHD3 GANAB TREH FKBP5 ALPL | 2.63e-06 | 1016 | 106 | 14 | 19056867 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.64e-06 | 283 | 106 | 8 | 30585729 | |
| Pubmed | FLNB DENND4A NRAP DSP OBSCN ABCF2 SORBS1 TRIM38 ZSCAN23 NOTCH2 | 3.04e-06 | 497 | 106 | 10 | 23414517 | |
| Pubmed | RBM15 DSP ANXA1 UGGT1 SPTBN2 SNAP23 CC2D1A PLD3 DENND1A GGCX XAB2 AIFM1 RBMX2 CTNNBL1 FLRT3 FBXO21 | 4.06e-06 | 1371 | 106 | 16 | 36244648 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 5.12e-06 | 219 | 106 | 7 | 31353912 | |
| Pubmed | FLNB RBM15 EPPK1 ERCC4 DDX17 DSP ANXA1 XAB2 CHCHD3 GANAB BRCA1 | 5.13e-06 | 652 | 106 | 11 | 31180492 | |
| Pubmed | FLNB RBM15 EPPK1 DSP ANXA1 UGGT1 SPTBN2 RSF1 RBM39 XAB2 GANAB | 5.21e-06 | 653 | 106 | 11 | 22586326 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RBM15 KRT8 DNAJC13 DDX17 DSP SPTBN2 ARHGAP39 PLD3 RBM39 XAB2 GANAB RBMX2 CTNNBL1 AGRN | 5.41e-06 | 1082 | 106 | 14 | 38697112 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB KRT8 EPPK1 DDX17 PPP2R2D DSP ANXA1 UGGT1 USP14 GANAB AIFM1 ZFHX3 | 6.73e-06 | 807 | 106 | 12 | 30575818 |
| Pubmed | FLNB AMPH GAK DNAJC13 DDX17 DSP ANXA1 SPTBN2 SORBS1 ARHGAP39 PLD3 GRM5 CBR1 RBM39 PLXNA4 RIMS1 | 6.97e-06 | 1431 | 106 | 16 | 37142655 | |
| Pubmed | DNAJB1 FLNB GAK UGGT1 SPTBN2 SNAP23 ABCF2 PLD3 DENND1A RBM39 USP14 GANAB AIFM1 PLEKHG3 FKBP5 ALPL | 7.53e-06 | 1440 | 106 | 16 | 30833792 | |
| Pubmed | FLNB KRT7 KRT8 DENND4A DDX17 DSP UGGT1 SPTBN2 RSF1 ABCF2 CHCHD3 TNRC18 BRCA1 RBMX2 PLXNA4 RIMS1 | 7.67e-06 | 1442 | 106 | 16 | 35575683 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | FLNB AMPD2 GAK DSP GOLM2 UGGT1 ABCF2 PLD3 RBM39 GGCX CHCHD3 GANAB AIFM1 AGRN NOTCH2 ALPL | 8.28e-06 | 1451 | 106 | 16 | 30550785 |
| Pubmed | FLNB CLSTN3 TTC28 SYNM DSP SPTBN2 CEP290 CTDSP1 SORBS1 TRIM68 TUBGCP5 CBR1 XAB2 CHCHD3 ALPL | 8.36e-06 | 1285 | 106 | 15 | 35914814 | |
| Pubmed | DNAJB1 FLNB RBM15 KRT8 DDX17 ABCF2 RBM39 KAT2B AIFM1 RBMX2 CTNNBL1 UTP3 FKBP5 | 8.38e-06 | 971 | 106 | 13 | 33306668 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 8.55e-06 | 90 | 106 | 5 | 35654790 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DNAJB1 FLNB GAK PPP2R2D UGGT1 ABCF2 CC2D1A CHCHD3 GANAB DUSP29 FBXO21 FKBP5 TNS3 | 8.66e-06 | 974 | 106 | 13 | 28675297 |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 8.68e-06 | 333 | 106 | 8 | 32665550 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 9.19e-06 | 564 | 106 | 10 | 21565611 | |
| Pubmed | Reproductive, Physiological, and Molecular Outcomes in Female Mice Deficient in Dhh and Ihh. | 9.20e-06 | 2 | 106 | 2 | 29788357 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33961838 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15878962 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21765473 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26034172 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25496840 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 32918598 | ||
| Pubmed | Lipocortin 1 co-associates with cytokeratins 8 and 18 in A549 cells via the N-terminal domain. | 9.20e-06 | 2 | 106 | 2 | 9459484 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24477235 | ||
| Pubmed | Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit. | 9.20e-06 | 2 | 106 | 2 | 21132007 | |
| Pubmed | Mutations in GDF5 presenting as semidominant brachydactyly A1. | 9.20e-06 | 2 | 106 | 2 | 20683927 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20971948 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DNAJB1 FLNB ANXA1 SPTBN2 SNAP23 CC2D1A SORBS1 SH3PXD2B NOTCH2 PHLDB2 | 9.33e-06 | 565 | 106 | 10 | 25468996 |
| Pubmed | FLNB GAK DNAJC13 EPPK1 DDX17 DSP UGGT1 SNAP23 DNAJB4 PLD3 XAB2 NSUN5 GANAB AIFM1 NOTCH2 | 9.33e-06 | 1297 | 106 | 15 | 33545068 | |
| Pubmed | DNAJB1 AMPD2 RBM15 DENND4A TTC28 SORBS1 DENND1A NOTCH2 PHLDB2 | 9.48e-06 | 446 | 106 | 9 | 24255178 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DNAJB1 FLNB KRT8 EPPK1 DDX17 DSP ANXA1 UGGT1 SPTBN2 DNAJB4 CBR1 RBM39 GANAB FKBP5 | 1.07e-05 | 1149 | 106 | 14 | 35446349 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KRT8 TTC28 DSP SPTBN2 CEP290 SNAP23 CC2D1A SORBS1 RBM39 SH3PXD2B GANAB AGRN | 1.17e-05 | 853 | 106 | 12 | 28718761 |
| Pubmed | DNAJB1 B4GALT7 SNAP23 ABCF2 ARHGAP39 DENND1A GGCX XAB2 NSUN5 BRCA1 PLEKHG3 RBMX2 CTNNBL1 ZFHX3 UTP3 AGRN | 1.22e-05 | 1497 | 106 | 16 | 31527615 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.41e-05 | 256 | 106 | 7 | 33397691 | |
| Pubmed | Differentiation of insulin-producing cells from human neural progenitor cells. | 1.50e-05 | 16 | 106 | 3 | 15839736 | |
| Pubmed | 1.50e-05 | 16 | 106 | 3 | 28760667 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | KRT8 DNAJC13 MYO9B ANXA1 SPTBN2 SNAP23 CBR1 AIFM1 PLEKHG3 MSANTD4 UTP3 | 1.51e-05 | 732 | 106 | 11 | 34732716 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.61e-05 | 477 | 106 | 9 | 31300519 | |
| Pubmed | GAK DNAJC13 TTC28 PPP2R2D UGGT1 ABCF2 TUBGCP5 GGCX NSUN5 UTP3 | 1.70e-05 | 606 | 106 | 10 | 36538041 | |
| Pubmed | 1.81e-05 | 17 | 106 | 3 | 23955340 | ||
| Pubmed | 2.50e-05 | 634 | 106 | 10 | 34591612 | ||
| Pubmed | RBM15 DDX17 MYO9B ABCF2 RBM39 USP14 CHCHD3 TNRC18 GANAB AIFM1 DOT1L FKBP5 PHLDB2 TNS3 | 2.64e-05 | 1247 | 106 | 14 | 27684187 | |
| Pubmed | [Hedgehog signaling pathway and its impact on development of cancer therapy]. | 2.76e-05 | 3 | 106 | 2 | 18788453 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17392501 | ||
| Pubmed | The role of nerve- versus muscle-derived factors in mammalian neuromuscular junction formation. | 2.76e-05 | 3 | 106 | 2 | 18367600 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25232867 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 31737127 | ||
| Pubmed | Keratin7 and Desmoplakin are involved in acute lung injury induced by sepsis through RAGE. | 2.76e-05 | 3 | 106 | 2 | 37660597 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19074837 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8849902 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18063705 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19228371 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9009843 | ||
| Pubmed | DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair. | 2.76e-05 | 3 | 106 | 2 | 39172790 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 10579908 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19920816 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 7527618 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24342078 | ||
| Pubmed | Comparative biological responses to human Sonic, Indian, and Desert hedgehog. | 2.76e-05 | 3 | 106 | 2 | 11472839 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNAJB1 FLNB RBM15 DENND4A DDX17 DSP UGGT1 ABCF2 CBR1 RBM39 CHCHD3 GANAB AIFM1 CTNNBL1 UTP3 | 2.80e-05 | 1425 | 106 | 15 | 30948266 |
| Pubmed | 3.40e-05 | 403 | 106 | 8 | 35253629 | ||
| Pubmed | DNAJB1 FLNB DNAJC13 DDX17 DSP ANXA1 ABCF2 RBM39 CHCHD3 GANAB AGRN | 3.53e-05 | 803 | 106 | 11 | 36517590 | |
| Pubmed | LPCAT1 TTC28 RSF1 TUBGCP5 GGCX KAT2B BRCA1 KMT5B CTNNBL1 ZFHX3 NOTCH2 PHLDB2 ALPL | 3.59e-05 | 1116 | 106 | 13 | 31753913 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.84e-05 | 533 | 106 | 9 | 30554943 | |
| Pubmed | 4.06e-05 | 22 | 106 | 3 | 16912273 | ||
| Pubmed | 4.33e-05 | 417 | 106 | 8 | 19199708 | ||
| Pubmed | FLNB AMPD2 AMPH DDX17 DSP ANXA1 SORBS1 ARHGAP39 GRM5 RBM39 CHCHD3 TNRC18 RIMS1 | 4.43e-05 | 1139 | 106 | 13 | 36417873 | |
| Pubmed | DNAJB1 GAK DNAJC13 SYNM UGGT1 SPTBN2 SNAP23 DNAJB4 CC2D1A PLD3 CHCHD3 GANAB AIFM1 FKBP5 NOTCH2 | 4.55e-05 | 1487 | 106 | 15 | 33957083 | |
| Pubmed | 4.66e-05 | 23 | 106 | 3 | 18297083 | ||
| Pubmed | 4.66e-05 | 23 | 106 | 3 | 19841136 | ||
| Pubmed | 4.70e-05 | 128 | 106 | 5 | 30995482 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DNAJB1 RBM15 DDX17 ABCF2 RBM39 XAB2 GANAB AIFM1 RBMX2 BTK CTNNBL1 AGRN FKBP5 NOTCH2 | 4.81e-05 | 1318 | 106 | 14 | 30463901 |
| Interaction | CFTR interactions | DNAJB1 FLNB KRT7 KRT8 LPCAT1 EPPK1 PPP2R2D DSP ANXA1 UGGT1 SNAP23 KATNAL1 PLD3 CBR1 RBM39 CHCHD3 GANAB AIFM1 TBR1 FBXO21 PHLDB2 TNS3 | 6.30e-06 | 1480 | 105 | 22 | int:CFTR |
| Interaction | CCDC8 interactions | FLNB EPPK1 DDX17 DSP MYO9B UGGT1 SPTBN2 CEP290 SNAP23 ABCF2 CHCHD3 AIFM1 PLEKHG3 PHLDB2 | 7.80e-06 | 656 | 105 | 14 | int:CCDC8 |
| Interaction | LRRC31 interactions | 1.20e-05 | 205 | 105 | 8 | int:LRRC31 | |
| Interaction | YWHAZ interactions | AMPD2 RBM15 ARL2BP KRT8 DENND4A B4GALT7 TTC28 PPP2R2D ANXA1 SPTBN2 RSF1 DNAJB4 SORBS1 CBR1 DENND1A RBM39 BRCA1 KMT5B PLEKHG3 PHLDB2 | 1.35e-05 | 1319 | 105 | 20 | int:YWHAZ |
| Interaction | YWHAH interactions | DNAJB1 AMPD2 RBM15 KRT8 DENND4A EPPK1 TTC28 DSP CEP290 CC2D1A SORBS1 DENND1A SH3PXD2B PLEKHG3 RIMS1 NOTCH2 PHLDB2 TNS3 | 1.45e-05 | 1102 | 105 | 18 | int:YWHAH |
| Interaction | OBSL1 interactions | FLNB RBM15 KRT8 DNAJC13 EPPK1 DDX17 DSP ANXA1 SPTBN2 RBM39 XAB2 CHCHD3 GANAB UTP3 NOTCH2 PHLDB2 | 1.69e-05 | 902 | 105 | 16 | int:OBSL1 |
| Interaction | XRCC6 interactions | DNAJB1 KRT8 DDX17 RASA1 MNX1 ANXA1 RBM39 XAB2 USP14 KAT2B TNRC18 GANAB BRCA1 ZFHX3 UTP3 FCHSD1 | 2.40e-05 | 928 | 105 | 16 | int:XRCC6 |
| Interaction | ACTA1 interactions | 2.42e-05 | 371 | 105 | 10 | int:ACTA1 | |
| Interaction | KHDRBS1 interactions | 2.53e-05 | 373 | 105 | 10 | int:KHDRBS1 | |
| Interaction | FNBP4 interactions | 2.80e-05 | 68 | 105 | 5 | int:FNBP4 | |
| Interaction | DNAJB5 interactions | 2.93e-05 | 114 | 105 | 6 | int:DNAJB5 | |
| Interaction | NPHP4 interactions | 3.30e-05 | 236 | 105 | 8 | int:NPHP4 | |
| Interaction | RAC1 interactions | FLNB RBM15 ARL2BP LPCAT1 ANXA1 SPTBN2 SNAP23 CTDSP1 CC2D1A ARHGAP39 RBM39 CHCHD3 PLEKHG3 NOTCH2 PHLDB2 TNS3 ALPL | 3.38e-05 | 1063 | 105 | 17 | int:RAC1 |
| Interaction | AAR2 interactions | FLNB KRT8 LPCAT1 EPPK1 DDX17 DSP ANXA1 CBR1 RBM39 XAB2 CHCHD3 GANAB AIFM1 | 3.71e-05 | 657 | 105 | 13 | int:AAR2 |
| Interaction | PRC1 interactions | FLNB AMPD2 RBM15 B4GALT7 EPPK1 DDX17 DSP SPTBN2 RSF1 GCGR CHCHD3 BRCA1 BTK UTP3 FBXO21 NOTCH2 | 4.24e-05 | 973 | 105 | 16 | int:PRC1 |
| Interaction | PRPF8 interactions | KRT7 KRT8 EPPK1 DDX17 DSP ANXA1 DNAJB4 RBM39 XAB2 USP14 AIFM1 DOT1L AGRN FKBP5 | 5.00e-05 | 776 | 105 | 14 | int:PRPF8 |
| Interaction | EFTUD2 interactions | DNAJB1 FLNB AMPD2 KRT8 DDX17 DSP ANXA1 UGGT1 DNAJB4 ABCF2 CC2D1A CBR1 RBM39 XAB2 USP14 BRCA1 AIFM1 CTNNBL1 DOT1L FKBP5 | 5.16e-05 | 1449 | 105 | 20 | int:EFTUD2 |
| Interaction | AR interactions | KRT8 GAK EPPK1 DDX17 RASA1 DSP TRIM68 XAB2 USP14 KAT2B TNRC18 BRCA1 BTK ZFHX3 DOT1L FKBP5 | 5.34e-05 | 992 | 105 | 16 | int:AR |
| Interaction | PHLPP1 interactions | 6.16e-05 | 333 | 105 | 9 | int:PHLPP1 | |
| Interaction | ACLY interactions | 6.45e-05 | 335 | 105 | 9 | int:ACLY | |
| Interaction | LZTS2 interactions | AMPD2 RBM15 KRT8 IGFN1 TTC28 SYNM DSP CEP290 SORBS1 CHCHD3 PHLDB2 | 7.40e-05 | 512 | 105 | 11 | int:LZTS2 |
| Interaction | PGR interactions | 7.77e-05 | 84 | 105 | 5 | int:PGR | |
| Interaction | LIMA1 interactions | FLNB DENND4A GAK DENND1A RBM39 USP14 AIFM1 PLEKHG3 DOT1L PHLDB2 | 8.20e-05 | 429 | 105 | 10 | int:LIMA1 |
| Interaction | USP53 interactions | 8.53e-05 | 138 | 105 | 6 | int:USP53 | |
| Interaction | PLD2 interactions | 8.88e-05 | 139 | 105 | 6 | int:PLD2 | |
| Interaction | RHOB interactions | LPCAT1 EPPK1 MYO9B SPTBN2 SNAP23 CTDSP1 CC2D1A ARHGAP39 CHCHD3 GANAB PLEKHG3 NOTCH2 PHLDB2 ALPL | 1.16e-04 | 840 | 105 | 14 | int:RHOB |
| Interaction | ARFGEF1 interactions | 1.21e-04 | 147 | 105 | 6 | int:ARFGEF1 | |
| Interaction | SIRT7 interactions | FLNB RBM15 EPPK1 DSP ANXA1 UGGT1 SPTBN2 RSF1 RBM39 XAB2 KAT2B GANAB CTNNBL1 | 1.30e-04 | 744 | 105 | 13 | int:SIRT7 |
| Interaction | AXL interactions | 1.34e-04 | 369 | 105 | 9 | int:AXL | |
| Interaction | NINL interactions | 1.40e-04 | 458 | 105 | 10 | int:NINL | |
| Interaction | FLNA interactions | FLNB RASA1 SPTBN2 GRM5 RBM39 USP14 BRCA1 AIFM1 PLEKHG3 BTK RIMS1 PHLDB2 | 1.41e-04 | 648 | 105 | 12 | int:FLNA |
| Interaction | BAP1 interactions | DNAJB1 FLNB KRT8 EPPK1 DDX17 DSP MYO9B ANXA1 UGGT1 SPTBN2 DNAJB4 CBR1 RBM39 NSUN5 GANAB BRCA1 TBR1 FKBP5 | 1.42e-04 | 1314 | 105 | 18 | int:BAP1 |
| Interaction | EED interactions | FLNB RBM15 KRT8 GAK DDX17 DSP UGGT1 CEP290 OBSCN ABCF2 CBR1 RBM39 XAB2 USP14 NSUN5 CHCHD3 BRCA1 PLEKHG3 AGRN | 1.55e-04 | 1445 | 105 | 19 | int:EED |
| Interaction | NBR1 interactions | 1.67e-04 | 380 | 105 | 9 | int:NBR1 | |
| Interaction | CDH1 interactions | DNAJB1 FLNB KRT8 ANXA1 SPTBN2 SNAP23 CC2D1A SORBS1 USP14 SH3PXD2B BRCA1 NOTCH2 PHLDB2 | 1.78e-04 | 768 | 105 | 13 | int:CDH1 |
| Interaction | DES interactions | 1.79e-04 | 158 | 105 | 6 | int:DES | |
| Interaction | FLNB interactions | 1.92e-04 | 304 | 105 | 8 | int:FLNB | |
| Interaction | RHOD interactions | LPCAT1 SPTBN2 SNAP23 CTDSP1 CC2D1A ARHGAP39 CHCHD3 PLEKHG3 IHH NOTCH2 TNS3 | 1.96e-04 | 572 | 105 | 11 | int:RHOD |
| Interaction | RHOC interactions | LPCAT1 RASA1 MYO9B SPTBN2 SNAP23 ARHGAP39 GANAB PLEKHG3 NOTCH2 PHLDB2 ALPL | 2.34e-04 | 584 | 105 | 11 | int:RHOC |
| Interaction | SYNM interactions | 2.38e-04 | 58 | 105 | 4 | int:SYNM | |
| Interaction | CEP72 interactions | 2.43e-04 | 107 | 105 | 5 | int:CEP72 | |
| Interaction | YWHAE interactions | AMPD2 RBM15 ARL2BP KRT8 DENND4A NRAP TTC28 SORBS1 CBR1 DENND1A RBM39 BRCA1 PLEKHG3 MSANTD4 DOT1L AGRN PHLDB2 | 2.57e-04 | 1256 | 105 | 17 | int:YWHAE |
| Interaction | BAG1 interactions | DNAJB1 KRT7 GAK DNAJC13 DDX17 BCORL1 DNAJB4 USP14 GANAB AIFM1 | 2.58e-04 | 494 | 105 | 10 | int:BAG1 |
| Interaction | ISG15 interactions | DNAJB1 FLNB EPPK1 DDX17 ANXA1 DNAJB4 ABCF2 USP14 GANAB AIFM1 | 2.58e-04 | 494 | 105 | 10 | int:ISG15 |
| Interaction | TAF15 interactions | 2.84e-04 | 408 | 105 | 9 | int:TAF15 | |
| Interaction | KIF23 interactions | FLNB LPCAT1 EPPK1 DDX17 DSP MYO9B ANXA1 RSF1 CHCHD3 TNRC18 BRCA1 UTP3 DOT1L FBXO21 PHLDB2 | 2.88e-04 | 1031 | 105 | 15 | int:KIF23 |
| Interaction | FES interactions | 2.89e-04 | 61 | 105 | 4 | int:FES | |
| Interaction | RND1 interactions | 3.06e-04 | 246 | 105 | 7 | int:RND1 | |
| Interaction | ATF2 interactions | 3.13e-04 | 247 | 105 | 7 | int:ATF2 | |
| Interaction | CRYZL1 interactions | 3.27e-04 | 26 | 105 | 3 | int:CRYZL1 | |
| Interaction | KRT18 interactions | 3.44e-04 | 419 | 105 | 9 | int:KRT18 | |
| Interaction | AGR2 interactions | FLNB KRT8 EPPK1 DDX17 NRAP PPP2R2D DSP ANXA1 UGGT1 USP14 GANAB AIFM1 ZFHX3 AGRN | 3.46e-04 | 934 | 105 | 14 | int:AGR2 |
| Interaction | NUDCD2 interactions | 3.76e-04 | 424 | 105 | 9 | int:NUDCD2 | |
| Interaction | CAV1 interactions | DNAJB1 KRT8 LPCAT1 DENND4A SPTBN2 SNAP23 CC2D1A ARHGAP39 PLD3 BTK FLRT3 NOTCH2 | 3.88e-04 | 724 | 105 | 12 | int:CAV1 |
| Interaction | DDX17 interactions | 3.89e-04 | 426 | 105 | 9 | int:DDX17 | |
| Interaction | CHMP4B interactions | FLNB AMPD2 EPPK1 DDX17 DSP UGGT1 SPTBN2 CC2D1A GCGR CHCHD3 PLEKHG3 RBMX2 | 4.02e-04 | 727 | 105 | 12 | int:CHMP4B |
| Interaction | CALM1 interactions | AMPH DENND4A GAK DNAJC13 RASA1 MYO9B CEP290 OBSCN GRM5 NSUN5 PLEKHG3 | 4.22e-04 | 626 | 105 | 11 | int:CALM1 |
| Interaction | RPS6KB2 interactions | 4.36e-04 | 261 | 105 | 7 | int:RPS6KB2 | |
| Interaction | CEBPB interactions | DNAJB1 FLNB DDX17 DSP ANXA1 SPTBN2 RSF1 SNAP23 ABCF2 DENND1A RBM39 XAB2 USP14 CHCHD3 KAT2B BRCA1 AIFM1 TNS3 | 4.47e-04 | 1443 | 105 | 18 | int:CEBPB |
| Interaction | FGFR1 interactions | DNAJB1 DNAJC13 RASA1 OBSCN ABCF2 CC2D1A FGF18 SH3PXD2B BTK FLRT3 KIT | 4.57e-04 | 632 | 105 | 11 | int:FGFR1 |
| Interaction | RHOJ interactions | RBM15 LPCAT1 SPTBN2 SNAP23 CTDSP1 CC2D1A CHCHD3 GANAB PLEKHG3 NOTCH2 PHLDB2 | 4.63e-04 | 633 | 105 | 11 | int:RHOJ |
| Interaction | NPM1 interactions | FLNB DNAJC13 DSP MYO9B BCORL1 DNAJB4 ABCF2 PLD3 RBM39 CHCHD3 BRCA1 RBMX2 CTNNBL1 UTP3 DOT1L AGRN | 4.74e-04 | 1201 | 105 | 16 | int:NPM1 |
| Interaction | CIT interactions | FLNB RBM15 EPPK1 DDX17 DSP MYO9B ANXA1 SPTBN2 RSF1 GCGR RBM39 XAB2 GANAB BRCA1 AIFM1 CTNNBL1 UTP3 FBXO21 | 4.74e-04 | 1450 | 105 | 18 | int:CIT |
| Interaction | SNRNP40 interactions | RBM15 DDX17 RSF1 RBM39 XAB2 USP14 BRCA1 CTNNBL1 ZFHX3 UTP3 DOT1L | 4.88e-04 | 637 | 105 | 11 | int:SNRNP40 |
| Interaction | HSPA2 interactions | 4.91e-04 | 440 | 105 | 9 | int:HSPA2 | |
| Interaction | HDLBP interactions | RBM15 DSP ANXA1 UGGT1 SNAP23 DENND1A GGCX XAB2 USP14 BRCA1 RBMX2 FLRT3 AGRN | 4.99e-04 | 855 | 105 | 13 | int:HDLBP |
| Interaction | DNAJB11 interactions | 5.03e-04 | 351 | 105 | 8 | int:DNAJB11 | |
| Interaction | RHOQ interactions | 5.07e-04 | 442 | 105 | 9 | int:RHOQ | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 7.83e-05 | 49 | 84 | 4 | 584 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.86e-04 | 8 | 84 | 2 | 939 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 5.86e-04 | 8 | 84 | 2 | 837 | |
| GeneFamily | SH2 domain containing | 1.26e-03 | 101 | 84 | 4 | 741 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.73e-03 | 206 | 84 | 5 | 682 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | FLNB KRT7 KRT8 DDX17 RSF1 SNAP23 KAT2B KMT5B ERCC6L2 ZFHX3 FBXO21 TRIM38 FKBP5 TNS3 | 4.73e-06 | 807 | 106 | 14 | M16651 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.69e-05 | 276 | 106 | 8 | M3063 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.69e-05 | 199 | 106 | 7 | M6264 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL | 2.65e-05 | 294 | 106 | 8 | M45674 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | KRT7 KRT8 DENND4A PPP2R2D DSP GOLM2 SNAP23 ABCF2 NSUN5 AIFM1 PLEKHG3 NOTCH2 PHLDB2 | 3.63e-05 | 843 | 106 | 13 | M2356 |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_DN | 5.02e-05 | 18 | 106 | 3 | M3506 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8 | 5.04e-05 | 50 | 106 | 4 | M16033 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8 | 5.89e-05 | 52 | 106 | 4 | MM874 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.65e-05 | 126 | 104 | 6 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | DNAJB1 KRT7 KRT8 DNAJB4 FGF18 TNRC18 BRCA1 RBMX2 PLXNA4 FLRT3 CCDC171 FBXO21 FKBP5 TNS3 | 6.75e-05 | 849 | 104 | 14 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 7.56e-05 | 46 | 104 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.52e-05 | 91 | 104 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_100 | 8.83e-05 | 18 | 104 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | KRT8 DSP ARHGAP39 PLD3 FGF18 TNRC18 DHH BRCA1 PLXNA4 CCDC171 FBXO21 FKBP5 NOTCH2 TNS3 | 1.04e-04 | 884 | 104 | 14 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 1.20e-04 | 156 | 104 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 2.85e-07 | 183 | 106 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-07 | 185 | 106 | 7 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | 15-Distal-Epithelial-Bud_tip_adjacent|Distal / Age, Tissue, Lineage and Cell class | 4.85e-07 | 198 | 106 | 7 | f4d9d5995a42f71bf412f0ad299fc963bad3a898 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-07 | 198 | 106 | 7 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.19e-07 | 200 | 106 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.32e-06 | 170 | 106 | 6 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-06 | 176 | 106 | 6 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 4.47e-06 | 179 | 106 | 6 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.47e-06 | 179 | 106 | 6 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 5.08e-06 | 183 | 106 | 6 | 9a4899afac0f91203209392c5f67b3d0aa356b86 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_CD56bright|COVID-19_Mild / Disease group, lineage and cell class | 5.24e-06 | 184 | 106 | 6 | f67308228bb6a5d624279fbb04db25a2f4087c9b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.41e-06 | 185 | 106 | 6 | 3a046c948524e5d0e986cd645e318d6930d7e0ee | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.41e-06 | 185 | 106 | 6 | 71d1a771026d9fa3528d46ac3d11353e396f2d87 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.41e-06 | 185 | 106 | 6 | 37b48218dd523049b57b13eb9cdb34e106cf91ea | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.41e-06 | 185 | 106 | 6 | df5d2309d19ac8d5e429afa785d0a480e75a8f9e | |
| ToppCell | ASK452-Immune-Mast_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.93e-06 | 188 | 106 | 6 | 840215e16cff90f821f776186284eafcf2350690 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 5.93e-06 | 188 | 106 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-06 | 188 | 106 | 6 | 2b8d70f761eda5509f21845a87cdb3602a639dd7 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-06 | 191 | 106 | 6 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | ASK452-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.69e-06 | 192 | 106 | 6 | 8269b88ff6073a908f547fcc7c5941f2e8289694 | |
| ToppCell | PND03-Epithelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-06 | 192 | 106 | 6 | d8c23693f690d4d568585537bbfedda05d505b3d | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.89e-06 | 193 | 106 | 6 | 54506c0da2f219f472b95e8935a78b657a8dec41 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.89e-06 | 193 | 106 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-06 | 193 | 106 | 6 | 5879efb38e6b3bf8c33c9a773632b1d726e3c153 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.89e-06 | 193 | 106 | 6 | c1817ad675b9f9d2d3436c8b9646edf89f0d4c82 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.89e-06 | 193 | 106 | 6 | 2d42721fac1bee294ede47d609bebb3e7d36bf0c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-06 | 193 | 106 | 6 | 725115a5ce3ef520b3ef469e96b8219b4c723fdd | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 6.89e-06 | 193 | 106 | 6 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-06 | 193 | 106 | 6 | abd7bcf318a2d895d8811c2ada8bfb4314fca3b1 | |
| ToppCell | E16.5-samps-Epithelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.89e-06 | 193 | 106 | 6 | 1cb5a1cffa2b4a3bfecca16b791c1992edeb237d | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.89e-06 | 193 | 106 | 6 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.52e-06 | 196 | 106 | 6 | cd507ee2baf4f52d6498811b3510d3164b56311f | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-06 | 196 | 106 | 6 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-06 | 196 | 106 | 6 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.74e-06 | 197 | 106 | 6 | b0fb5774525ba05f60c635d42f14bb8d79bff17c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-06 | 197 | 106 | 6 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.74e-06 | 197 | 106 | 6 | bbb7c106d5b96b8e95aeb3e5c293e104fceea234 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.97e-06 | 198 | 106 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.97e-06 | 198 | 106 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.20e-06 | 199 | 106 | 6 | 8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | Biopsy_IPF-Epithelial-Transitional_AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 8.20e-06 | 199 | 106 | 6 | 83ff8b7e472d1212324c05cc719b746d19e5e23b | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.20e-06 | 199 | 106 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.20e-06 | 199 | 106 | 6 | 0c060ef64341659f4b1247d0264ac12e53a7e12e | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Mild / Disease, condition lineage and cell class | 8.44e-06 | 200 | 106 | 6 | bb21e26a8b7cbceddb1ab5163a223a186d914da4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | cellseq-Epithelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.44e-06 | 200 | 106 | 6 | e4204c4b864346f47d76b0f0faae96f04fed5082 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Transitional_AT2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | dfa897ef5ce4744c77b6e5ee5a0d6d83229d1691 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.44e-06 | 200 | 106 | 6 | c6f211bbadd0c9be776c58807249e06764df47dc | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.44e-06 | 200 | 106 | 6 | 8d1c78dd829cbc290820d5118f24ff7f828a8622 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | 0afd93c4fdcc118bcfa77f3b59f6ff7d9293a7a4 | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.44e-06 | 200 | 106 | 6 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.44e-06 | 200 | 106 | 6 | 5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67 | |
| ToppCell | mild-NK_CD56bright|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.44e-06 | 200 | 106 | 6 | 6de701985a0b92a7dece1b0e4a76e13756ccc0dd | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | e3a80626941363bfc9d97ef906d38c97080aecb1 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.44e-06 | 200 | 106 | 6 | 992bd6b1feac2afded6eb927ac95ddf5cfef961c | |
| ToppCell | Cerebellum-Macroglia-CSF_related|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 137 | 106 | 5 | f004199b654143e9e766e5c5f56858089e98cf5f | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 137 | 106 | 5 | 6a5599af9d0ee1be6cac17af09aa4cd50774c683 | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 137 | 106 | 5 | 01cbc9082e10ef51a1763a8b2d708eea0434490f | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 137 | 106 | 5 | a22730b6f78b66bb3c46155af37c34e554672dee | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 137 | 106 | 5 | ce7c57dad201bd2164fc8b1172aca709f3f7def2 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.07e-05 | 139 | 106 | 5 | 9e2a84d5ed7232b70eadbba754d9ca13f2d50fe9 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 2.70e-05 | 147 | 106 | 5 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | VE-CD8-memory_CD4|VE / Condition, Cell_class and T cell subcluster | 3.17e-05 | 152 | 106 | 5 | 9401b7770c1bdc87eba25e82922f5dd1c4fa37ee | |
| ToppCell | 18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class | 3.82e-05 | 158 | 106 | 5 | 183f445967e09e871c93d8e94781ed9fec894169 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.05e-05 | 160 | 106 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-05 | 164 | 106 | 5 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-05 | 164 | 106 | 5 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.69e-05 | 165 | 106 | 5 | b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-05 | 167 | 106 | 5 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-05 | 167 | 106 | 5 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.11e-05 | 168 | 106 | 5 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.11e-05 | 168 | 106 | 5 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.11e-05 | 168 | 106 | 5 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / Disease condition and Cell class | 5.56e-05 | 171 | 106 | 5 | 5810f790012a0750ca3378595514f66a99f123be | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-05 | 173 | 106 | 5 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-05 | 173 | 106 | 5 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.20e-05 | 175 | 106 | 5 | 0ed053aa8353c72ff37fee830672704a3ddc7d85 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.20e-05 | 175 | 106 | 5 | 0124a3c4696b39cee8b566e94603d1d3d128bfa5 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 175 | 106 | 5 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-05 | 175 | 106 | 5 | e219b61d6bc078d44ea7d06191d3462654d857a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-05 | 175 | 106 | 5 | bd16c80418bf71127e6f1e50edf83967c9218b42 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.37e-05 | 176 | 106 | 5 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-05 | 177 | 106 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-05 | 178 | 106 | 5 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-05 | 178 | 106 | 5 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-05 | 178 | 106 | 5 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 179 | 106 | 5 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 179 | 106 | 5 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.90e-05 | 179 | 106 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.90e-05 | 179 | 106 | 5 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | mild_COVID-19-NK_CD56bright|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.09e-05 | 180 | 106 | 5 | d8b418edd807a51c0b5f4018b8b478dcc65892a7 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.27e-05 | 181 | 106 | 5 | c3dbf8850d3812fbb770798f4cf38908db8bb92b | |
| Disease | brachydactyly type A1 (is_implicated_in) | 1.23e-05 | 2 | 104 | 2 | DOID:0110964 (is_implicated_in) | |
| Disease | Brachydactyly type A1 | 3.68e-05 | 3 | 104 | 2 | cv:C1862151 | |
| Disease | BRACHYDACTYLY, TYPE A1 (disorder) | 3.68e-05 | 3 | 104 | 2 | C1862151 | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 1 (implicated_via_orthology) | 7.35e-05 | 4 | 104 | 2 | DOID:0110305 (implicated_via_orthology) | |
| Disease | congenital myopathy 21 (implicated_via_orthology) | 7.35e-05 | 4 | 104 | 2 | DOID:0081353 (implicated_via_orthology) | |
| Disease | Disproportionate short stature | 1.62e-04 | 77 | 104 | 4 | C0878659 | |
| Disease | osteoarthritis, knee | 2.48e-04 | 158 | 104 | 5 | EFO_0004616 | |
| Disease | glypican-1 measurement | 2.55e-04 | 7 | 104 | 2 | EFO_0801649 | |
| Disease | sick sinus syndrome | 3.40e-04 | 8 | 104 | 2 | MONDO_0001823 | |
| Disease | familial sick sinus syndrome | 3.40e-04 | 8 | 104 | 2 | MONDO_0012061 | |
| Disease | Testicular Neoplasms | 3.40e-04 | 8 | 104 | 2 | C0039590 | |
| Disease | Leukemia, Myelocytic, Acute | 3.76e-04 | 173 | 104 | 5 | C0023467 | |
| Disease | sunburn | 3.77e-04 | 96 | 104 | 4 | EFO_0003958 | |
| Disease | pancreatic carcinoma | 3.86e-04 | 174 | 104 | 5 | EFO_0002618 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.11e-04 | 41 | 104 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.11e-04 | 41 | 104 | 3 | C0858252 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 4.36e-04 | 9 | 104 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | vitamin B6 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0004621 | |
| Disease | Basal cell carcinoma | 6.63e-04 | 11 | 104 | 2 | C0007117 | |
| Disease | age at menopause | 7.17e-04 | 302 | 104 | 6 | EFO_0004704 | |
| Disease | cup-to-disc ratio measurement | 8.39e-04 | 430 | 104 | 7 | EFO_0006939 | |
| Disease | male infertility (implicated_via_orthology) | 9.36e-04 | 13 | 104 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | breast carcinoma | AMPD2 LPCAT1 NRAP TTC28 MYO9B SPTBN2 HNF4G KMT5B NBPF10 DOT1L NOTCH2 | 9.43e-04 | 1019 | 104 | 11 | EFO_0000305 |
| Disease | Squamous cell carcinoma | 9.88e-04 | 124 | 104 | 4 | C0007137 | |
| Disease | bipolar disorder | 1.01e-03 | 577 | 104 | 8 | MONDO_0004985 | |
| Disease | idiopathic pulmonary fibrosis | 1.08e-03 | 57 | 104 | 3 | EFO_0000768 | |
| Disease | developmental dysplasia of the hip | 1.43e-03 | 16 | 104 | 2 | EFO_1000648 | |
| Disease | Prostate cancer, familial | 1.88e-03 | 69 | 104 | 3 | C2931456 | |
| Disease | colorectal cancer (is_marker_for) | 2.35e-03 | 157 | 104 | 4 | DOID:9256 (is_marker_for) | |
| Disease | advanced glycosylation end product-specific receptor ligand measurement | 2.47e-03 | 21 | 104 | 2 | EFO_0010762 | |
| Disease | Antihypertensive use measurement | 2.51e-03 | 265 | 104 | 5 | EFO_0009927 | |
| Disease | risky sexual behaviour measurement | 3.06e-03 | 169 | 104 | 4 | EFO_0007877 | |
| Disease | Neoplasm of the genitourinary tract | 3.23e-03 | 24 | 104 | 2 | cv:C0042065 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 3.23e-03 | 24 | 104 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | blood phosphate measurement | 3.40e-03 | 174 | 104 | 4 | EFO_0010972 | |
| Disease | Fanconi Anemia | 3.50e-03 | 25 | 104 | 2 | C0015625 | |
| Disease | response to mTOR inhibitor | 3.50e-03 | 25 | 104 | 2 | EFO_0005417 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSDTKLELNSGRRYG | 101 | Q9UG63 | |
| DRDNYSERALRKLCG | 296 | Q9BQT9 | |
| KQTGTRERGRYREEE | 31 | Q8WYA6 | |
| EYDFERGRRGSKKGS | 41 | Q06187 | |
| DEKRYNERISGLGLT | 91 | O95831 | |
| YDLAVARKEAGLGRR | 86 | Q6TFL3 | |
| SKGRRRKDDYAEAGT | 566 | Q9NZU0 | |
| RDRRLEFRYDLGKGA | 1696 | O00468 | |
| GETLLQRAARLGYKD | 1496 | Q5H9F3 | |
| RAEGYNLKDEDGRLR | 136 | Q66LE6 | |
| YGRKSRRADLGTADT | 46 | Q99440 | |
| AGEKSSEKGLRERAY | 841 | Q8TEK3 | |
| LDYRAEKEGRGLDLS | 126 | Q9Y2Y0 | |
| LYKEQGEGQGDRSLR | 196 | Q01433 | |
| LARGASDEEIKRAYR | 11 | P25685 | |
| AEGTRLQRELRGYLA | 51 | P49418 | |
| LGYNSLSKDEVRRGD | 906 | Q7Z401 | |
| YKNLSSGAETREGLR | 16 | Q86UQ8 | |
| DRFGTIRTIDYRKGD | 476 | Q96T37 | |
| SDRNSRRSKGIAYVE | 186 | Q14498 | |
| KSRTAYSGGAEDLER | 226 | Q9Y388 | |
| AEERLRQAGKSGSYL | 191 | P20936 | |
| RQAGKSGSYLIRESD | 196 | P20936 | |
| LRDQRLGVKSGDYST | 436 | Q9C0H5 | |
| YQGRASSLDDLRALK | 161 | Q96P11 | |
| YRKLLEGEESRLESG | 391 | P05787 | |
| SDARALYEAGERRKG | 201 | P04083 | |
| GKREGIDQSYQLLRD | 396 | O94952 | |
| LDSANEKGLYRRGEA | 346 | Q13451 | |
| RYSRADAAKRLLDAG | 1886 | Q04721 | |
| DDGLRRATYERGVKV | 346 | Q8IV08 | |
| RTRRTGKGLGYNSDE | 101 | Q5VUJ9 | |
| DLDRYSERARMKGGE | 351 | Q8NF37 | |
| LYRTLSDADRKGGNS | 176 | P43026 | |
| SSGETLRYKDRRLAQ | 871 | P41594 | |
| RRLRSPNDDISGYKE | 266 | Q92831 | |
| DRSLYGKEDNDTLVR | 121 | P10721 | |
| ITNERLYKAAGEDAR | 1231 | Q86VF7 | |
| TYRKLLEGEESRLAG | 391 | P08729 | |
| DKGSGRRLRDLRDSD | 341 | P50219 | |
| LKRDEENRGSYTEGL | 781 | Q4FZB7 | |
| REDDEFYRRIKGAGL | 226 | Q9UBV7 | |
| DARRAKVYGRGLSEG | 2001 | O75369 | |
| RIKERLQSCYRGEGT | 366 | Q9HCM2 | |
| GNYVKDLSRLGRDLR | 186 | Q9GZU7 | |
| RRISARGEDGDKYAQ | 71 | O76093 | |
| GLLRTRYSQKIGDDL | 196 | P47871 | |
| QAGARDAERKSLYTL | 581 | Q96RT8 | |
| EGYLRRKGLFSRAEI | 541 | Q96M69 | |
| DRQYDSRGRFGELLL | 276 | Q14541 | |
| GAYGASVSDEELKRR | 51 | Q9NX63 | |
| SRRLEKGRSQDYPDT | 316 | Q86UR5 | |
| RKGSETLRDGDRYCL | 3306 | Q5VST9 | |
| KGSETLRDGDRYSLR | 3571 | Q5VST9 | |
| LRDGDRYSLRQDGTK | 3576 | Q5VST9 | |
| YESDEKARGTRLDGL | 236 | P05186 | |
| RYRDLAGGTGRSAKE | 106 | Q86WN1 | |
| GYRRGAKKLESSEEN | 1201 | P38398 | |
| GSGREYALKRLLSNE | 61 | O14976 | |
| LNADGRSYRSEDKIL | 186 | Q9UDY4 | |
| YEDTGDLKVNNGTRR | 81 | Q9NZS2 | |
| DEATALDRYRLQKAG | 66 | Q68J44 | |
| KETLLSRRGEDSDYR | 191 | O15078 | |
| SRRGEDSDYRSQLSK | 196 | O15078 | |
| TSDRDRNKYGLLARL | 151 | O43323 | |
| YDDLRRGRSEADSDK | 1731 | P15924 | |
| YTEAARRLGNDGSRD | 916 | Q6P1N0 | |
| DGSRDAAKEALYRRN | 926 | Q6P1N0 | |
| RALRDFLRKEYGGLD | 71 | P16152 | |
| RTDFSEGKITGRRYN | 101 | O75165 | |
| SGDFDDGFLRRKQRR | 21 | A6NNA5 | |
| YQRLDLGGSERSRGV | 611 | Q8TEH3 | |
| RSGKDGRLDIYGERR | 416 | Q86VF2 | |
| VKDGGRRDSASYRDR | 591 | Q92841 | |
| DYRRLDGSTKSEERL | 561 | Q5T890 | |
| AGGERDLRRLYSVDA | 2126 | O95180 | |
| VRKRGRSTDEYSEAD | 1271 | Q96T23 | |
| KEEQRYSGELSGIRA | 456 | Q9NQZ2 | |
| SDRDRNKYGLLARLA | 156 | Q14623 | |
| IDQKEADYGRLSSRL | 81 | Q6P4E1 | |
| ADYGRLSSRLQAREG | 86 | Q6P4E1 | |
| SRDKDYRARGRDDKG | 151 | Q9BW62 | |
| ARYGGRKLERARDLF | 566 | Q9HCS7 | |
| RLRDYEAGLGLKSNE | 211 | O00635 | |
| SSDSGIYEQAKRRRI | 626 | Q16650 | |
| SYRDRRDKVAAGASE | 471 | O15061 | |
| EKLREGRDASRSLYE | 111 | Q6P3W6 | |
| KYASRDEARRAGGGR | 1056 | A1L390 | |
| EELRNLGLYVKTRDG | 481 | Q14697 | |
| SEDRRQDLLSRYRAG | 3531 | P58107 | |
| YALGREGRNREELFS | 126 | Q7Z4S9 | |
| SGGYIKRITNDARED | 136 | O00161 | |
| RLRKLSLGQYDNDAG | 771 | Q68CZ2 | |
| YTGRDSERALRLSEK | 131 | Q86SQ0 | |
| GEQRTGTEVKRRYLD | 61 | Q8NCY6 | |
| GLASALESYRGRDRL | 6 | Q96HA9 | |
| LTSDDYELGAGIRKR | 1561 | O15417 | |
| IRLRKGNEYRAGTDE | 396 | Q6AZZ1 | |
| QERGLSSLDRKYLDG | 81 | P38435 | |
| YAGLKELAGERRERL | 1676 | O15020 | |
| RRDNTEARGGLKPEY | 21 | Q8N2H3 | |
| GREKELLSSQRDGRF | 311 | A1X283 | |
| REESGQYERKAERGA | 1121 | Q9BX66 | |
| RFSGSKDVARNRGYL | 86 | P12018 | |
| LLDRYGDRLTSGAKL | 546 | O43280 | |
| DLGNKREEARAYSNL | 386 | Q96AY4 | |
| GGSTEEQRYLTALRK | 611 | Q92889 | |
| DALKRYAGALRASGE | 131 | P54578 | |
| LGIDSAYDRNRKEAR | 606 | Q9NYU2 | |
| EGKDGERRELTNDRY | 2306 | Q15911 | |
| YGDTCDREGRLEKQR | 226 | Q3MJ62 | |
| EGLYRKSGAANRTRE | 1731 | Q13459 |